IBDEI1BF ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22364,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22364,1,4,0)
 ;;=4^C82.09
 ;;^UTILITY(U,$J,358.3,22364,2)
 ;;=^5001470
 ;;^UTILITY(U,$J,358.3,22365,0)
 ;;=C82.00^^87^981^65
 ;;^UTILITY(U,$J,358.3,22365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22365,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Unspec Site
 ;;^UTILITY(U,$J,358.3,22365,1,4,0)
 ;;=4^C82.00
 ;;^UTILITY(U,$J,358.3,22365,2)
 ;;=^5001461
 ;;^UTILITY(U,$J,358.3,22366,0)
 ;;=C82.19^^87^981^66
 ;;^UTILITY(U,$J,358.3,22366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22366,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22366,1,4,0)
 ;;=4^C82.19
 ;;^UTILITY(U,$J,358.3,22366,2)
 ;;=^5001480
 ;;^UTILITY(U,$J,358.3,22367,0)
 ;;=C82.10^^87^981^67
 ;;^UTILITY(U,$J,358.3,22367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22367,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Unspec Site
 ;;^UTILITY(U,$J,358.3,22367,1,4,0)
 ;;=4^C82.10
 ;;^UTILITY(U,$J,358.3,22367,2)
 ;;=^5001471
 ;;^UTILITY(U,$J,358.3,22368,0)
 ;;=C82.29^^87^981^68
 ;;^UTILITY(U,$J,358.3,22368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22368,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22368,1,4,0)
 ;;=4^C82.29
 ;;^UTILITY(U,$J,358.3,22368,2)
 ;;=^5001490
 ;;^UTILITY(U,$J,358.3,22369,0)
 ;;=C82.20^^87^981^69
 ;;^UTILITY(U,$J,358.3,22369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22369,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Unspec Site
 ;;^UTILITY(U,$J,358.3,22369,1,4,0)
 ;;=4^C82.20
 ;;^UTILITY(U,$J,358.3,22369,2)
 ;;=^5001481
 ;;^UTILITY(U,$J,358.3,22370,0)
 ;;=C82.39^^87^981^70
 ;;^UTILITY(U,$J,358.3,22370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22370,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22370,1,4,0)
 ;;=4^C82.39
 ;;^UTILITY(U,$J,358.3,22370,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,22371,0)
 ;;=C82.30^^87^981^71
 ;;^UTILITY(U,$J,358.3,22371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22371,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
 ;;^UTILITY(U,$J,358.3,22371,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,22371,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,22372,0)
 ;;=C82.49^^87^981^72
 ;;^UTILITY(U,$J,358.3,22372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22372,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22372,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,22372,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,22373,0)
 ;;=C82.40^^87^981^73
 ;;^UTILITY(U,$J,358.3,22373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22373,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
 ;;^UTILITY(U,$J,358.3,22373,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,22373,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,22374,0)
 ;;=C82.99^^87^981^74
 ;;^UTILITY(U,$J,358.3,22374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22374,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22374,1,4,0)
 ;;=4^C82.99
 ;;^UTILITY(U,$J,358.3,22374,2)
 ;;=^5001550
 ;;^UTILITY(U,$J,358.3,22375,0)
 ;;=C82.90^^87^981^75
 ;;^UTILITY(U,$J,358.3,22375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22375,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,22375,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,22375,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,22376,0)
 ;;=R59.1^^87^981^60
 ;;^UTILITY(U,$J,358.3,22376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22376,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Generalized
